Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation Following Cataract Surgery

Clinical trial NCT01298752 · TERMINATED

Trial details

NCT number: NCT01298752
Sponsor: Bausch & Lomb Incorporated
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Inflammation Pain Cataract

Start date: 2011-02-01
Primary completion: 2011-09-01
Enrollment: 177

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.